Submission of Audited Financial Results for the quarter and year ended 31st March, 2026

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.0%1-day move

₹19.90

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+0.0+3.0+2.5+2.5-2.5+0.6+0.5+5.5——

Up moveDown movePending

AI summary

Nexus Surgical and Medicare Limited reported strong annual performance for FY2026. Total income grew 37.9% to Rs. 789.63 lakhs from Rs. 572.83 lakhs in the previous year. Profit after tax increased 48% to Rs. 73.61 lakhs versus Rs. 49.74 lakhs. EPS improved from Rs. 0.91 to Rs. 1.35 per share. The company maintained positive operating cash flow of Rs. 17.31 lakhs. The statutory auditor issued an unmodified (unqualified) opinion on the financial results. The board also appointed M/s. VMRS & Co. as internal auditors for FY2026-27.

Likely market impact

The company demonstrated robust growth with revenue and profit both showing strong double-digit increases. Positive cash flow and clean audit opinion are encouraging signs for investors. The stock is listed on BSE with script code 538874.